{
    "relation": [
        [
            "Creators",
            "Begovac, Josip",
            "Lisi\u0107, Miroslav",
            "Lukas, Davorka",
            "Mareti\u0107, Tomislav",
            "Kniewald, Tihana",
            "Nowotny, Thomas E."
        ],
        [
            "Email",
            "",
            "",
            "",
            "",
            "",
            ""
        ]
    ],
    "pageTitle": "Marked improvement in survival among adult Croatian AIDS patients after the introduction of highly active antiretroviral treatment - Repozitorij Medicinskog fakulteta Sveu\u010dili\u0161ta u Zagrebu",
    "title": "",
    "url": "http://medlib.mef.hr/480/",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 5,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988962.66/warc/CC-MAIN-20150728002308-00115-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 164403875,
    "recordOffset": 164395673,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampAfterTable": "{5179=We compared the survival of patients following the first AIDS event in Croatia from the period 1986-1996 to the period 1997-2000. A total of 72 (81.8%) out of 88 patients from 1986-1996 and 18 (32.1%) out of 56 from 1997-2000 died. Survival following the first AIDS-defining illness markedly improved in the period 1997-2000 compared to the period 1986-1996 (adjusted Hazard Ratio (HR) for patients surviving more than 6 months: 0.11, 95% confidence interval (95% CI) = 0.04-0.29). A CD4+ cell count of < 100 x 10(6)/L was an independent risk factor for patients surviving up to 2 years (adjusted HR = 1.96, 95% CI = 1.1-3.43, p = 0.02). Patients with tuberculosis or fungal infections had a longer survival when compared to other diagnosis (adjusted HR = 0.53, 95% CI = 0.32-0.90, p = 0.01). However, despite dramatic survival benefit of combination antiretroviral therapy, mortality at six months following the first AIDS event was similar in the two study periods and the one-year probability of death was still substantial (27.2%) in the period 1997-2000., 4030=Usporedili smo pre\u017eivljavanje bolesnika nakon dijagnoze AIDS-a u Hrvatskoj u razdoblju 1986\u20131996. g. s razdobljem 1997\u2013 2000. g. 72 (81,8%) od 88 bolesnika iz 1986\u20131996. g. i 18 (32,1%) od 56 iz 1997\u20132000. g. je umrlo. Pre\u017eivljavanje nakon prve AIDS-definiraju\u0107e bolesti se zna\u010dajno pobolj\u0161alo u razdoblju 1997\u20132000 u odnosu na razdoblje 1986\u20131996 (prilago\u0111eni omjer hazarda (HR) za bolesnike koji su pre\u017eivjeli vi\u0161e od 6 mjeseci: 0,11, 95% CI: 0,04\u20130,29). Broj CD4+ limfocita < 100 x 10na6/L je tako\u0111er bio neovisni \u010dimbenik pre\u017eivljavanja za bolesnike koji su pre\u017eivjeli 2 godine (prilago\u0111eni HR=1,96, 95%CI=1,1\u20133,43, p=0,02). Bolesnici s tuberkulozom ili gljivi\u010dnom infekcijom imali su bolje pre\u017eivljavanje u usporedbi s drugim dijagnozama (prilago\u0111eni HR=0,53, 95%CI=0,32\u20130,90, p=0,01). Me\u0111utim, usprkos izrazito boljem pre\u017eivljavanju zbog kombinirane antiretrovirusne terapije, smrtnost 6 mjeseci od AIDS-a je bila sli\u010dna u oba razdoblja, a smrtnost nakon jedne godine od AIDS-a je bila jo\u0161 uvijek zna\u010dajna (27,2%) u razdoblju 1997\u20132000.}",
    "textBeforeTable": "Creators: Published Status: Boris \u010ci\u010dova\u010dki Depositing User: Katedra za infektologiju Divisions: Acquired Immunodeficiency Syndrome - drug therapy - mortality ; Antiretroviral Therapy, Highly Active ; Survival Analysis ; Adolescent ; Adult ; Croatia ; Female ; Humans ; Male ; Prospective Studies ; Retrospective Studies MeSH: Article Item Type: We compared the survival of patients following the first AIDS event in Croatia from the period 1986-1996 to the period 1997-2000. A total of 72 (81.8%) out of 88 patients from 1986-1996 and 18 (32.1%) out of 56 from 1997-2000 died. Survival following the first AIDS-defining illness markedly improved in the period 1997-2000 compared to the period 1986-1996 (adjusted Hazard Ratio (HR) for patients surviving more than 6 months: 0.11, 95% confidence interval (95% CI) = 0.04-0.29). A CD4+ cell count of < 100 x 10(6)/L was an independent risk factor for patients surviving up to 2 years (adjusted HR = 1.96, 95% CI = 1.1-3.43, p = 0.02). Patients with tuberculosis or fungal infections had a longer survival when compared to other diagnosis (adjusted HR = 0.53, 95% CI = 0.32-0.90, p = 0.01). However, despite dramatic survival benefit of combination antiretroviral therapy, mortality at six months following the first AIDS event was similar in the two study periods",
    "textAfterTable": "Date: March 2006 Date Deposited: 15 Oct 2008 Last Modified: 23 Sep 2011 18:10 Subjects: / Related URLs: URI: http://medlib.mef.hr/id/eprint/480 Actions (login required) View Item Document Downloads More statistics for this",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}